Annabel Kartal-Allen - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Annabel Kartal-Allen's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Annabel Kartal-Allen

Annabel Kartal-Allen

Verified

News Reporter, Nutraceutical Business Review

Reading

Final Covers

Cycling

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 62

  • Trump's tariffs: an expert's take on pharmaceutical impact, where to go from here

    By Annabel Kartal-Allen Verified| Manufacturing Chemist Verified The Trump Administration has decided to double down on its plan to slap tariffs on pharmaceutical imports, as revealed from live coverage from .  This follows Donald J. Trump's decision to place baseline tariffs of 10% on almost every US import — though pharmaceuticals are currently exempted from this cost. “We’re going to put tariffs on the pharmaceutical companies, and they’re going to all want to come back,” he noted in a conversation with the press.

    By Annabel Kartal-Allen Verified · Manufacturing Chemist

    Apr. 10, 2025

  • KitoZyme launches weight management-focused functional fibre blend, KiOLIFE

    By Annabel Kartal-Allen Verified| Nutraceutical Business Review Verified By Annabel Kartal-Allen | Published: 7-Apr-2025 The fungal chitosan and chitin-glucan based nutraceutical is designed to support weight management through the regulation of blood sugar and cholesterol levels You need to be a subscriber to read this article. Click here to find out more. Nutraceutical manufacturer KitoZyme has debuted a new supplement/functional food ingredient for weight management and gut health, KiOLIFE.

    By Annabel Kartal-Allen Verified · Nutraceutical Business Review

    Apr. 07, 2025

  • Trump's tariffs: an expert's take on pharmaceutical impact, where to go from here

    By Annabel Kartal-Allen Verified| Manufacturing Chemist Verified The Trump Administration has decided to double down on its plan to slap tariffs on pharmaceutical imports, as revealed from live coverage from .  This follows Donald J. Trump's decision to place baseline tariffs of 10% on almost every US import — though pharmaceuticals are currently exempted from this cost. “We’re going to put tariffs on the pharmaceutical companies, and they’re going to all want to come back,” he noted in a conversation with the press.

    By Annabel Kartal-Allen Verified · Manufacturing Chemist

    Apr. 10, 2025

As seen in

Company Info

Nutraceutical Business Review

Reading, United Kingdom